Skip to main content
Top
Published in: Modern Rheumatology 5/2008

01-10-2008 | Original Article

Adult-onset Still’s disease: a report of 28 cases and review of the literature

Authors: Golbarg Mehrpoor, Mohammad Bagher Owlia, Hossein Soleimani, Jamshid Ayatollahi

Published in: Modern Rheumatology | Issue 5/2008

Login to get access

Abstract

Adult-onset Still’s disease (AOSD) is a rare systemic inflammatory disorder of unknown etiology. It is characterized by fever, skin rash, polyarthralgias or polyarthritis, sore throat, hepatosplenomegaly, lymphadenopathy, leukocytosis, liver enzyme elevation, and high serum level of ferritin. Several kinds of skin lesions have been reported in this condition. The aim of this study was to assess the clinical and laboratory aspects of 28 patients with AOSD in central Iran. According to the diagnostic criteria of AOSD, we identified 28 patients between 2002 and 2007. We intended to describe the clinical characteristics, treatment, and outcome of our patients with AOSD. Of 28 patients with AOSD, 21 (75%) were female, 7 (25%) were male. Fever (100%), sore throat (92%), Arthralgia (92%), dermatographism (92%), typical rash (85%) and arthritis (60%) were the most common findings. The mean values of laboratory findings were as follows; C-reactive protein (CRP) level of 14.4 mg/dl, erythrocyte sedimentation rate (ESR) of 91.5 mm/h, leukocyte count of 15744.4/μl. Abnormal levels of aspartate aminotransferase and alanine aminotransferase were observed in 25 (89%) patients. Twenty patients (71%) had high ferritin values (>500 ng/ml). The clinical characteristics were similar to previous series. A febrile polyarthritis was the most frequent presentation form. Dermatographism was frequently encountered phenomenon in our patients with AOSD. Being that dermatographism is a simple inducible skin reaction, along with its sensitivity in active disease, we suggest more controlled studies to validate accuracy and positive predictive value of it in convenient clinical setting in the diagnosis of AOSD and to consider including it in diagnostic criteria.
Literature
2.
go back to reference Bannatyne GA, Wohlmann AS. Rheumatoid arthritis: its clinical history, etiology and pathology. Lancet. 1896;1:1120–5.CrossRef Bannatyne GA, Wohlmann AS. Rheumatoid arthritis: its clinical history, etiology and pathology. Lancet. 1896;1:1120–5.CrossRef
3.
go back to reference Meijvis SC, Endeman H, Geers AB, ter Borg EJ. Extremely high serum ferritin levels as diagnostic tool in adult-onset Still’s disease. Neth J Med. 2007;65(6):212–4.PubMed Meijvis SC, Endeman H, Geers AB, ter Borg EJ. Extremely high serum ferritin levels as diagnostic tool in adult-onset Still’s disease. Neth J Med. 2007;65(6):212–4.PubMed
4.
go back to reference Larson EB. Adult Still’s disease: recognition of a clinical syndrome and recent experience. West J Med. 1985;142(5):665–71.PubMed Larson EB. Adult Still’s disease: recognition of a clinical syndrome and recent experience. West J Med. 1985;142(5):665–71.PubMed
5.
go back to reference Rheumatic diseases, John J. Cush, Arthur Kavanaugh, C. Michael Stein. Rheumatology Diagnosis and Therapies, 2nd edn. Philadelphia: Lippincott, Baltimore: Williams and Wilkins; 2005. p. 110–2. Rheumatic diseases, John J. Cush, Arthur Kavanaugh, C. Michael Stein. Rheumatology Diagnosis and Therapies, 2nd edn. Philadelphia: Lippincott, Baltimore: Williams and Wilkins; 2005. p. 110–2.
6.
go back to reference Cagatay Y, Gul A, Cagatay A, Kamali S, Karadeniz A, Inanc M, Ocal L, Aral O, Konice M. Adult- onset Still’s disease. Int J Clin Pract. 2007;1–6, Published Online: 18 May 2007. Cagatay Y, Gul A, Cagatay A, Kamali S, Karadeniz A, Inanc M, Ocal L, Aral O, Konice M. Adult- onset Still’s disease. Int J Clin Pract. 2007;1–6, Published Online: 18 May 2007.
7.
go back to reference Pouchot J, Sampalis JS, Beaudet F, et al. Adult-onset Still’s disease: manifestations, disease course and outcome in 62 patients. Medicine (Baltimore). 1991;70:118. Pouchot J, Sampalis JS, Beaudet F, et al. Adult-onset Still’s disease: manifestations, disease course and outcome in 62 patients. Medicine (Baltimore). 1991;70:118.
8.
go back to reference Edward D, Harris JR. Clinical features of rheumatoid arthritis, Kelley`s textbook of rheumatology, 7th edn. Saunders: Elsevier; 2005. p. 1047–8. Edward D, Harris JR. Clinical features of rheumatoid arthritis, Kelley`s textbook of rheumatology, 7th edn. Saunders: Elsevier; 2005. p. 1047–8.
9.
go back to reference Chen DY, Lan JL, Hsieh TY, Chen YH. Clinical manifestations, disease course, and complications of adult-onset Still’s disease in Taiwan. J Formos Med Assoc. 2004;103(11):844–52.PubMed Chen DY, Lan JL, Hsieh TY, Chen YH. Clinical manifestations, disease course, and complications of adult-onset Still’s disease in Taiwan. J Formos Med Assoc. 2004;103(11):844–52.PubMed
10.
go back to reference Wouters JM, Van de putte LB. Adult-onset Still′s disease: clinical and laboratory features, treatment and progress of 45 cases. Q J Med. 1986;61:1055–6.PubMed Wouters JM, Van de putte LB. Adult-onset Still′s disease: clinical and laboratory features, treatment and progress of 45 cases. Q J Med. 1986;61:1055–6.PubMed
11.
go back to reference Kelly J, Chowienczyk P, Gibson T. Sore throat and hyperferritinaemia. J R Soc Med. 2001;94:400–1.PubMed Kelly J, Chowienczyk P, Gibson T. Sore throat and hyperferritinaemia. J R Soc Med. 2001;94:400–1.PubMed
12.
go back to reference Nguyen KH, Weisman MH. Severe sore throat as a presenting symptom of adult-onset Still’s disease: a case series and review of the literature. J Rheumatol. 1997;24:592.PubMed Nguyen KH, Weisman MH. Severe sore throat as a presenting symptom of adult-onset Still’s disease: a case series and review of the literature. J Rheumatol. 1997;24:592.PubMed
13.
go back to reference Chen DY, Lan HH, Hsieh TY, Chen HH, Lan JL. Crico-thyroid perichondritis leading to sore throat in patients with active adult-onset Still’s disease. Ann Rheum Dis. 2007;66(9):1264–6.PubMedCrossRef Chen DY, Lan HH, Hsieh TY, Chen HH, Lan JL. Crico-thyroid perichondritis leading to sore throat in patients with active adult-onset Still’s disease. Ann Rheum Dis. 2007;66(9):1264–6.PubMedCrossRef
14.
go back to reference Bambery P, Thomas RJ, Malhotra HS, Kaur U, Bhusnurmath SR, Deodhar SD. Adult-onset Still’s disease: clinical experience with 18 patients over 15 years in northern India. Ann Rheum Dis. 1992;51:529–32.PubMedCrossRef Bambery P, Thomas RJ, Malhotra HS, Kaur U, Bhusnurmath SR, Deodhar SD. Adult-onset Still’s disease: clinical experience with 18 patients over 15 years in northern India. Ann Rheum Dis. 1992;51:529–32.PubMedCrossRef
15.
go back to reference Mert A, Ozaras R, Tabak F, Bilir M, Ozturk R, Ozdogan H, et al. Fever of unknown origin: a review of 20 patients with adult-onset Still’s disease. Clin Rheumatol. 2003;22(2):89–93.PubMedCrossRef Mert A, Ozaras R, Tabak F, Bilir M, Ozturk R, Ozdogan H, et al. Fever of unknown origin: a review of 20 patients with adult-onset Still’s disease. Clin Rheumatol. 2003;22(2):89–93.PubMedCrossRef
16.
go back to reference Tabak F, Mert A, Celik AD, et al. Fever of unknown origin in Turkey. Infection. 2003;31:417–20.PubMed Tabak F, Mert A, Celik AD, et al. Fever of unknown origin in Turkey. Infection. 2003;31:417–20.PubMed
17.
go back to reference Crispín JC, Martínez-Baños D, Alcocer-Varela J. Adult-onset Still disease as the cause of fever of unknown origin. Medicine (Baltimore). 2005;84(6):331–7.CrossRef Crispín JC, Martínez-Baños D, Alcocer-Varela J. Adult-onset Still disease as the cause of fever of unknown origin. Medicine (Baltimore). 2005;84(6):331–7.CrossRef
18.
go back to reference Owlia MB. Clinical spectrum of connective tissue disorders. JIACM. 2006;7(3):217–24. Owlia MB. Clinical spectrum of connective tissue disorders. JIACM. 2006;7(3):217–24.
19.
go back to reference Prendiville JS, Tucker LB, Cabral DA, Crawford RI. A pruritic linear urticarial rash, fever, and systemic inflammatory disease in five adolescents: adult-onset Still disease or systemic juvenile idiopathic arthritis sine arthritis? Pediatr Dermatol. 2004;21(5):580–8.PubMedCrossRef Prendiville JS, Tucker LB, Cabral DA, Crawford RI. A pruritic linear urticarial rash, fever, and systemic inflammatory disease in five adolescents: adult-onset Still disease or systemic juvenile idiopathic arthritis sine arthritis? Pediatr Dermatol. 2004;21(5):580–8.PubMedCrossRef
20.
go back to reference Affleck AG, Littlewood SM. Adult-onset Still’s disease with atypical cutaneous features. J Eur Acad Dermatol Venereol. 2005;19(3):360–3.PubMedCrossRef Affleck AG, Littlewood SM. Adult-onset Still’s disease with atypical cutaneous features. J Eur Acad Dermatol Venereol. 2005;19(3):360–3.PubMedCrossRef
21.
go back to reference Kaur S, Bambery P, Dhar S. Persistent dermal plaque lesions in adult-onset Still's disease. Dermatology. 1994;188(3):241–2.PubMedCrossRef Kaur S, Bambery P, Dhar S. Persistent dermal plaque lesions in adult-onset Still's disease. Dermatology. 1994;188(3):241–2.PubMedCrossRef
22.
go back to reference Thien Huong NT, Pitche P, Minh Hoa T, Laurent R. Persistent pigmented plaques in adult-onset Still’s disease. Ann Dermatol Venereol. 2005;132:693–6.PubMedCrossRef Thien Huong NT, Pitche P, Minh Hoa T, Laurent R. Persistent pigmented plaques in adult-onset Still’s disease. Ann Dermatol Venereol. 2005;132:693–6.PubMedCrossRef
23.
go back to reference Fernández-Guarino M, González C, Bardal Ruiz A, Calvo Pulido M, Harto Castaño A, Jaén Olasolo P. Adult Still’s disease with atypical skin manifestations. Actas Dermosifiliogr. 2006;97(9):591–3.PubMed Fernández-Guarino M, González C, Bardal Ruiz A, Calvo Pulido M, Harto Castaño A, Jaén Olasolo P. Adult Still’s disease with atypical skin manifestations. Actas Dermosifiliogr. 2006;97(9):591–3.PubMed
24.
go back to reference Criado RF, Criado PR, Vasconcellos C, Szajubok JC, Michalany NS, Kadunc BV, et al. Urticaria as a cutaneous sign of adult-onset Still’s disease. J Cutan Med Surg. 2006;10(2):99–103.PubMed Criado RF, Criado PR, Vasconcellos C, Szajubok JC, Michalany NS, Kadunc BV, et al. Urticaria as a cutaneous sign of adult-onset Still’s disease. J Cutan Med Surg. 2006;10(2):99–103.PubMed
25.
go back to reference Lee JB, Kim JW, Lee SS, Kim SJ, Won YH, Lee SC. Adult-onset Still’s disease with vesiculopustules on the hands and feet. J Korean Med Sci. 2002;17(6):852–5 12483016. Lee JB, Kim JW, Lee SS, Kim SJ, Won YH, Lee SC. Adult-onset Still’s disease with vesiculopustules on the hands and feet. J Korean Med Sci. 2002;17(6):852–5 12483016.
26.
go back to reference Grattan CEH, Kobza Black A. Urticaria and mastocytosis. In: Burns T, Breathnach S, Cox N, Griffiths C. Rook′s textbook of dermatology, vol. 47. 7th edn. Oxford: Blackwell; 2004. p. 17–8. Grattan CEH, Kobza Black A. Urticaria and mastocytosis. In: Burns T, Breathnach S, Cox N, Griffiths C. Rook′s textbook of dermatology, vol. 47. 7th edn. Oxford: Blackwell; 2004. p. 17–8.
27.
go back to reference Taşkapan O, Harmanyeri Y. Evaluation of patients with symptomatic dermographism. J Eur Acad Dermatol Venereol. 2006;20(1):58–62.PubMedCrossRef Taşkapan O, Harmanyeri Y. Evaluation of patients with symptomatic dermographism. J Eur Acad Dermatol Venereol. 2006;20(1):58–62.PubMedCrossRef
28.
go back to reference Adcock BB, Hornsby LB, Jenkins K. Dermographism: an adverse effect of atorvastatin. J Am Board Fam Pract. 2001;14(2):148–51.PubMed Adcock BB, Hornsby LB, Jenkins K. Dermographism: an adverse effect of atorvastatin. J Am Board Fam Pract. 2001;14(2):148–51.PubMed
29.
go back to reference Fautrel B, Zing E, Golmard JL, Le Moel G, Bissery A, Rioux C, et al. Proposal for a new set of classification criteria for adult-onset Still's disease. Medicine (Baltimore). 2002;81:194–200.CrossRef Fautrel B, Zing E, Golmard JL, Le Moel G, Bissery A, Rioux C, et al. Proposal for a new set of classification criteria for adult-onset Still's disease. Medicine (Baltimore). 2002;81:194–200.CrossRef
30.
go back to reference Appenzeller S, Castro GR, Costallat LT, Samara AM, Bértolo MB. Adult-onset Still's disease in southeast Brazil. J Clin Rheumatol. 2005;11(2):76–80.PubMedCrossRef Appenzeller S, Castro GR, Costallat LT, Samara AM, Bértolo MB. Adult-onset Still's disease in southeast Brazil. J Clin Rheumatol. 2005;11(2):76–80.PubMedCrossRef
31.
go back to reference Chandran V, Aggarwal A, Misra R. Adult-onset Still’s disease. J Indian Rheumatol Assoc. 2002;10:19–21. Chandran V, Aggarwal A, Misra R. Adult-onset Still’s disease. J Indian Rheumatol Assoc. 2002;10:19–21.
32.
go back to reference Owlia MB, Soleimani H, Haji Ghasemian SH. Adult-onset Still's disease presenting first in pregnancy (case report). J Shahid Sadoughi University of Medical Sciences. 2003;11(2):67–70. Owlia MB, Soleimani H, Haji Ghasemian SH. Adult-onset Still's disease presenting first in pregnancy (case report). J Shahid Sadoughi University of Medical Sciences. 2003;11(2):67–70.
33.
go back to reference Singh S, Samant R, Joshi VR. Adult-onset Still’s disease: a study of 14 cases. Clin Rheumatol. 2008;27(1):35–9.PubMedCrossRef Singh S, Samant R, Joshi VR. Adult-onset Still’s disease: a study of 14 cases. Clin Rheumatol. 2008;27(1):35–9.PubMedCrossRef
34.
go back to reference Van Reeth C, Le Moel G, Revenant Lasne Y, Agneray MC, Kahn MF J, Bourgeois P. Serum ferritin and isoferritins are tools for diagnosis of active adult Still’s disease. J Rheumatol. 1994;21(5):890–5.PubMed Van Reeth C, Le Moel G, Revenant Lasne Y, Agneray MC, Kahn MF J, Bourgeois P. Serum ferritin and isoferritins are tools for diagnosis of active adult Still’s disease. J Rheumatol. 1994;21(5):890–5.PubMed
35.
go back to reference Fautrel B, Le Moel G, Saint-Marcoux B, Taupin P, Vignes S, Rozenberg S, et al. Diagnostic value of ferritin and glycosylated ferritin in adult-onset Still’s disease. J Rheumatol. 2001;28:322–9.PubMed Fautrel B, Le Moel G, Saint-Marcoux B, Taupin P, Vignes S, Rozenberg S, et al. Diagnostic value of ferritin and glycosylated ferritin in adult-onset Still’s disease. J Rheumatol. 2001;28:322–9.PubMed
36.
go back to reference Vignes S, Le Moel G, Fautrel B, Wechsler B, Godeau P, Piette JC. Percentage of glycosylated serum ferritin remains low throughout the course of adult-onset Still’s disease. Ann Rheum Dis. 2000;59:347–50.PubMedCrossRef Vignes S, Le Moel G, Fautrel B, Wechsler B, Godeau P, Piette JC. Percentage of glycosylated serum ferritin remains low throughout the course of adult-onset Still’s disease. Ann Rheum Dis. 2000;59:347–50.PubMedCrossRef
37.
go back to reference Owlia MB, Soleimani H, Mortazavizadeh MR. Macrophage Activation Syndrome (MAS) and Thrombotic Thrombocytopenic Purpura (TTP)–Are they from a single spectrum? JIACM. 2005;6(4):337–40. Owlia MB, Soleimani H, Mortazavizadeh MR. Macrophage Activation Syndrome (MAS) and Thrombotic Thrombocytopenic Purpura (TTP)–Are they from a single spectrum? JIACM. 2005;6(4):337–40.
38.
go back to reference Kadar J, Petrovicz E. Adult-onset Still’s disease. Best Pract Res Clin Rheumatol. 2004;18:663–76.PubMedCrossRef Kadar J, Petrovicz E. Adult-onset Still’s disease. Best Pract Res Clin Rheumatol. 2004;18:663–76.PubMedCrossRef
39.
go back to reference Kraetsch HG, Antoni C, Kalden JR, Manger B. Successful treatment of a small cohort of patients with adult-onset of Still’s disease with infliximab: first experiences. Ann Rheum Dis. 2001;60:iii55–7.PubMed Kraetsch HG, Antoni C, Kalden JR, Manger B. Successful treatment of a small cohort of patients with adult-onset of Still’s disease with infliximab: first experiences. Ann Rheum Dis. 2001;60:iii55–7.PubMed
40.
go back to reference Kurasawa M, Kotani K, Kurasawa G, Shida K, Yamada S, Tago T. Adult-onset Still’s disease in a patient over 80 years old successfully treated with low-dose methotrexate therapy. Age Ageing. 2007;36(1):104–6.PubMedCrossRef Kurasawa M, Kotani K, Kurasawa G, Shida K, Yamada S, Tago T. Adult-onset Still’s disease in a patient over 80 years old successfully treated with low-dose methotrexate therapy. Age Ageing. 2007;36(1):104–6.PubMedCrossRef
41.
go back to reference López Rodríguez M, García Arias M, Gómez Cerezo. Biological therapy with anti-TNF antibodies. Extending the spectrum of its indications? J Rev Clin Esp. 2007;207(9):448–50. López Rodríguez M, García Arias M, Gómez Cerezo. Biological therapy with anti-TNF antibodies. Extending the spectrum of its indications? J Rev Clin Esp. 2007;207(9):448–50.
42.
go back to reference Efthimiou P, Kontzias A, Ward CM, Ogden NS. Adult-onset Still’s disease: can recent advances in our understanding of its pathogenesis lead to targeted therapy? Nat Clin Pract Rheumatol. 2007;3(6):328–35.PubMedCrossRef Efthimiou P, Kontzias A, Ward CM, Ogden NS. Adult-onset Still’s disease: can recent advances in our understanding of its pathogenesis lead to targeted therapy? Nat Clin Pract Rheumatol. 2007;3(6):328–35.PubMedCrossRef
43.
go back to reference Furst DE, Breedveld FC, Kalden JR, Smolen JS, Burmester GR, Sieper J, et al. Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2007. Ann Rheum Dis. 2007;66(3):iii2–22.PubMedCrossRef Furst DE, Breedveld FC, Kalden JR, Smolen JS, Burmester GR, Sieper J, et al. Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2007. Ann Rheum Dis. 2007;66(3):iii2–22.PubMedCrossRef
44.
go back to reference Efthimiou P, Markenson JA. Role of biological agents in immune-mediated inflammatory diseases. South Med J. 2005;98:192–204.PubMedCrossRef Efthimiou P, Markenson JA. Role of biological agents in immune-mediated inflammatory diseases. South Med J. 2005;98:192–204.PubMedCrossRef
45.
go back to reference Cavagna L, Caporali R, Epis O, Bobbio-Pallavicini F, Montecucco C. Infliximab in the treatment of adult Still’s disease refractory to conventional therapy. Clin Exp Rheumatol. 2001;19:329–32.PubMed Cavagna L, Caporali R, Epis O, Bobbio-Pallavicini F, Montecucco C. Infliximab in the treatment of adult Still’s disease refractory to conventional therapy. Clin Exp Rheumatol. 2001;19:329–32.PubMed
46.
go back to reference Kokkinos A, Iliopoulos A, Greka P, Efthymiou A, Katsilambros N, Sfikakis PP. Successful treatment of refractory adult-onset Still’s disease with infliximab. A prospective, non-comparative series of four patients. Clin Rheumatol. 2004;23:45–9.PubMedCrossRef Kokkinos A, Iliopoulos A, Greka P, Efthymiou A, Katsilambros N, Sfikakis PP. Successful treatment of refractory adult-onset Still’s disease with infliximab. A prospective, non-comparative series of four patients. Clin Rheumatol. 2004;23:45–9.PubMedCrossRef
47.
go back to reference Olivieri I, de Stefano G, Padula A, La Gala A, de Stefano C. Infliximab in a case of early adult-onset Still’s disease. Clin Rheumatol. 2003;22:369–70.PubMedCrossRef Olivieri I, de Stefano G, Padula A, La Gala A, de Stefano C. Infliximab in a case of early adult-onset Still’s disease. Clin Rheumatol. 2003;22:369–70.PubMedCrossRef
48.
go back to reference Thonhofer R, Soleiman A, Kriessmayr M, Thonhofer U, Wipfler E, Gaugg M, et al. Decrease of proteinuria in a patient with adult-onset Still’s disease and glomerulonephritis after anti-TNFalpha therapy. Scand J Rheumatol. 2006;35(6):485–8.PubMedCrossRef Thonhofer R, Soleiman A, Kriessmayr M, Thonhofer U, Wipfler E, Gaugg M, et al. Decrease of proteinuria in a patient with adult-onset Still’s disease and glomerulonephritis after anti-TNFalpha therapy. Scand J Rheumatol. 2006;35(6):485–8.PubMedCrossRef
49.
go back to reference Husni ME, Maier AL, Mease PJ, Overman SS, Fraser P, Gravallese EM, et al. Etanercept in the treatment of adult patients with Still’s disease. Arthritis Rheum. 2002;46:1171–6.PubMedCrossRef Husni ME, Maier AL, Mease PJ, Overman SS, Fraser P, Gravallese EM, et al. Etanercept in the treatment of adult patients with Still’s disease. Arthritis Rheum. 2002;46:1171–6.PubMedCrossRef
50.
go back to reference Kuek A, Weerakoon A, Ahmed K, Ostör AJ. Adult-onset Still’s disease and myocarditis: successful treatment with intravenous immunoglobulin and maintenance of remission with etanercept. Rheumatology (Oxford). 2007;46(6):1043–4.CrossRef Kuek A, Weerakoon A, Ahmed K, Ostör AJ. Adult-onset Still’s disease and myocarditis: successful treatment with intravenous immunoglobulin and maintenance of remission with etanercept. Rheumatology (Oxford). 2007;46(6):1043–4.CrossRef
51.
go back to reference Kumari R, Uppal SS. Prolonged remission in adult-onset Still’s disease with etanercept. Clin Rheumatol. 2006;25(1):106–8.PubMedCrossRef Kumari R, Uppal SS. Prolonged remission in adult-onset Still’s disease with etanercept. Clin Rheumatol. 2006;25(1):106–8.PubMedCrossRef
52.
go back to reference Asherson RA, Pascoe L. Adult-onset Still’s disease: response to Enbrel. Ann Rheum Dis. 2002;61:859–60.PubMedCrossRef Asherson RA, Pascoe L. Adult-onset Still’s disease: response to Enbrel. Ann Rheum Dis. 2002;61:859–60.PubMedCrossRef
53.
go back to reference Serratrice J, Granel B, Disdier P, Weiller PJ, Dussol B. Resolution with etanercept of nephrotic syndrome due to renal AA amyloidosis in adult Still’s disease. Am J Med. 2003;115:589–90.PubMedCrossRef Serratrice J, Granel B, Disdier P, Weiller PJ, Dussol B. Resolution with etanercept of nephrotic syndrome due to renal AA amyloidosis in adult Still’s disease. Am J Med. 2003;115:589–90.PubMedCrossRef
54.
go back to reference Fitzgerald AA, Leclercq SA, Yan A, Homik JE, Dinarello CA. Rapid responses to anakinra in patients with refractory adult-onset Still’s disease. Arthritis Rheum. 2005;52(6):1794–803.PubMedCrossRef Fitzgerald AA, Leclercq SA, Yan A, Homik JE, Dinarello CA. Rapid responses to anakinra in patients with refractory adult-onset Still’s disease. Arthritis Rheum. 2005;52(6):1794–803.PubMedCrossRef
55.
go back to reference Kötter I, Wacker A, Koch S, Henes J, Richter C, Engel A, et al. Anakinra in Patients with Treatment-Resistant Adult-Onset Still’s Disease: Four Case Reports with Serial Cytokine Measurements and a Review of the Literature. Semin Arthritis Rheum. 2007;37(3):189–97 (Epub 2007 Jun 20).PubMedCrossRef Kötter I, Wacker A, Koch S, Henes J, Richter C, Engel A, et al. Anakinra in Patients with Treatment-Resistant Adult-Onset Still’s Disease: Four Case Reports with Serial Cytokine Measurements and a Review of the Literature. Semin Arthritis Rheum. 2007;37(3):189–97 (Epub 2007 Jun 20).PubMedCrossRef
56.
go back to reference Quartuccio L, De Vita S. Interleukin 1 receptor antagonist therapy-induced thrombocytopenia in adult-onset Still’s disease. J Rheumatol. 2007;34(4):892–3.PubMed Quartuccio L, De Vita S. Interleukin 1 receptor antagonist therapy-induced thrombocytopenia in adult-onset Still’s disease. J Rheumatol. 2007;34(4):892–3.PubMed
57.
go back to reference Godinho F, Santos MJ, Canas Da Silva J. Refractory adult-onset Still’s disease successfully treated with anakinra. Ann Rheum Dis. 2005;64:647–8.CrossRef Godinho F, Santos MJ, Canas Da Silva J. Refractory adult-onset Still’s disease successfully treated with anakinra. Ann Rheum Dis. 2005;64:647–8.CrossRef
58.
go back to reference Ahmadi-Simab K, Lamprecht P, Jankowiak C, Gross WL. Successful treatment of refractory adult-onset Still’s disease with rituximab. Ann Rheum Dis. 2006;65(8):1117–8.PubMedCrossRef Ahmadi-Simab K, Lamprecht P, Jankowiak C, Gross WL. Successful treatment of refractory adult-onset Still’s disease with rituximab. Ann Rheum Dis. 2006;65(8):1117–8.PubMedCrossRef
Metadata
Title
Adult-onset Still’s disease: a report of 28 cases and review of the literature
Authors
Golbarg Mehrpoor
Mohammad Bagher Owlia
Hossein Soleimani
Jamshid Ayatollahi
Publication date
01-10-2008
Publisher
Springer Japan
Published in
Modern Rheumatology / Issue 5/2008
Print ISSN: 1439-7595
Electronic ISSN: 1439-7609
DOI
https://doi.org/10.1007/s10165-008-0104-6

Other articles of this Issue 5/2008

Modern Rheumatology 5/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.